This chapter examines the influence of emerging weight loss drugs on consumer behavior and the food industry, particularly regarding junk food consumption. It discusses how companies are adapting to shifting dietary trends and the rising demand for healthier products in response to these medications. The narrative also addresses the ongoing concerns about ultra-processed foods and their health implications, highlighting the industry's efforts to redefine its products amidst these challenges.
Snack-food companies have long shown their adaptability to changing diets. How could the rise of appetite-suppressing drugs and fears about ultra-processed foods change the food we consume? How hearing aids and other lifestyle choices can reduce your risk of dementia (11:00). And why it’s time to revive the siesta (17:11).
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.